Lobe-specific proteome changes in the dorsal-lateral and ventral prostate of TRAMP mice versus wild-type mice

Proteomics

Volumn 11, Issue 12, 2011, Pages 2542-2549

  Zhang, Jinhui ^a   Wang, Lei ^a   Zhang, Yong ^a   Li, Li ^a   Higgins, Leeann ^a   Lü, Junxuan ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Biomedicine; ITRAQ; Lobe; Prostate cancer; TRAMP mouse

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE VENTRAL LOBE; PROTEIN ANALYSIS; PROTEOMICS;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN INTERACTION MAPPING; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

MUS;

EID: 79958142657     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100008     Document Type: Article

References (19)

1. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D. et al., Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995, 92, 3439-3443.
2. Chiaverotti, T., Couto, S. S., Donjacour, A., Mao, J. H. et al., Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am. J. Pathol. 2008, 172, 236-246.
3. Ahlgren, G., Pedersen, K., Lundberg, S., Aus, G. et al., Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate 2000, 42, 274-279.
4. Wang, L., Bonorden, M. J., Li, G. X., Lee, H. J. et al., Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. 2009, 2, 484-495.
5. Zhang, J., Wang, L., Anderson, L. B., Witthuhn, B. et al., Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer Prevent. Res. 2010, 3, 994-1006.
6. Akkina, S. K., Zhang, Y., Nelsestuen, G. L., Oetting, W. S., Ibrahlm, H. N., Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition? J. Proteome Res. 2009, 8, 94-103.
7. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A. et al., The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 2007, 6, 1638-1655.
8. Fujimoto, N., Akimoto, Y., Suzuki, T., Kitamura, S., Ohta, S., Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J. Endocrinol. 2006, 190, 793-803.
9. Fujimoto, N., Suzuki, T., Ohta, S., Kitamura, S., Identification of rat prostatic secreted proteins using mass spectrometric analysis and androgen-dependent mRNA expression. J. Androl. 2009, 30, 669-678.
10. Berquin, I. M., Min, Y., Wu, R., Wu, H., Chen, Y. Q., Expression signature of the mouse prostate. J. Biol. Chem. 2005, 280, 36442-36451.
11. Sharma, A., Ray, R., Rajeswari, M. R., Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin. Cancer Investig. 2008, 26, 843-851.
12. Lin, J. F., Xu, J., Tian, H. Y., Gao, X. et al., Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int. J. Cancer 2007, 121, 2596-2605.
13. Meehan, K. L., Holland, J. W., Dawkins, H. J., Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 2002, 50, 54-63.
14. Ouyang, X., DeWeese, T. L., Nelson, W. G., Abate-Shen, C., Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res. 2005, 65, 6773-6779.
15. Rizzi, F., Bettuzzi, S., The clusterin paradigm in prostate and breast carcinogenesis. Endocr. Relat. Cancer 2010, 17, R1-R17.
16. Hu, Y., Sun, H., Owens, R. T., Wu, J. et al., Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 2009, 11, 1042-1053.
17. Sugiura, T., Nagano, Y., Noguchi, Y., DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biol. Ther. 2007, 6, 957-964.
18. Wang, J., Eltoum, I. E., Lamartiniere, C. A., Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol. Cell. Endocrinol. 2004, 219, 171-180.
19. Shukla, S., Maclennan, G. T., Marengo, S. R., Resnick, M. I., Gupta, S., Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005, 64, 224-239.